Laylaa 28 20 mcg (Ethinyl Estradiol TABLET) 20 MCG

LAYLAA 28 20 MCG is an oral contraceptive tablet containing ethinyl estradiol. It is commonly used for birth control and may help regulate menstrual cycles. This medication is manufactured by Lupin Pharma Canada Limited.

Strength

20 MCG

Manufacturer / TM Owner

LUPIN PHARMA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LAYLAA 28 20 MCG is primarily used as a birth control pill to prevent pregnancy. It contains ethinyl estradiol, a synthetic estrogen, which works by inhibiting ovulation and altering the cervical mucus. This medication may also be prescribed to manage irregular menstrual cycles or reduce symptoms of premenstrual syndrome (PMS).

Side Effects

Common effects of LAYLAA 28 20 MCG may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience breast tenderness, nausea, or headaches. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

LAYLAA 28 20 MCG should be used under the guidance of a healthcare provider. It is important to follow the prescribed dosage and schedule. Smoking, especially in women over 35, can increase the risk of serious side effects. Regular check-ups are recommended to monitor for any adverse effects.

Avoid Interactions

LAYLAA 28 20 MCG may interact with certain medications, including antibiotics, anticonvulsants, and HIV medications. These interactions can affect the effectiveness of the contraceptive. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

LAYLAA 28 20 MCG is primarily used as a birth control pill to prevent pregnancy and may also help regulate menstrual cycles.

LAYLAA 28 20 MCG should be taken orally, following the prescribed dosage and schedule provided by your healthcare provider.

Common side effects may include changes in menstrual bleeding, breast tenderness, nausea, and headaches.

Smoking, especially in women over 35, can increase the risk of serious side effects. It is advisable to discuss this with your healthcare provider.

If you miss a dose, follow the instructions provided by your healthcare provider or refer to the patient information leaflet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.